By Kuldip K. Ambastha
Sonoma Pharmaceuticals Inc. (SNOA) is a specialty pharmaceutical company focused on conditions which could be treated using stabilized hypochlorous acid (HOCl or HClO) in various ways. The company’s stock had a volatile end for this past trading week, with a gain of +50.6% on Thursday, August 19, 2021 followed by a loss of -23.9% on Friday, August 20, 2021. On Thursday, the company announced the release of two new and highly innovative dental offerings – OroGenix Oral Hygiene Rinse and Microdacyn® Oral Care – which left investors impressed and led to the gain in the stock price seen. On Friday in the absence of any new information, it seems investors sold off the company’s stock to realize actual profits from the gains observed on the prior trading day. The stock market can be like a roller coaster going up and down, as seen in the stock price of Sonoma Pharmaceuticals Inc. on these two consecutive trading days.
Keywords – Sonoma Pharmaceuticals Inc., Sonoma Pharmaceuticals, Sonoma, specialty, pharmaceutical, hypochlorous acid, HOCl, HClO, OroGenix Oral Hygiene Rinse, Microdacyn® Oral Care.
Disclosure – The principals and clients of Ambastha Financial LLC have no positions in SNOA.
Disclaimer – No recommendations are being made via this post. Past performance is not an indicator of future performance. As an investor, you should do your own research and seek professional advice from a Registered Investment Adviser (RIA). You can lose money by investing in stocks and other instruments. Ambastha Financial LLC does not assume any responsibility (legal or otherwise) for any losses that may occur as a result of actions taken based on this post. All content copyrighted © 2021 – Ambastha Financial LLC.